[ Skip to the content ]

Institute of Formal and Applied Linguistics Wiki

[ Back to the navigation ]

You are here: start » projects » content-annotation » guess » article-1

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision 		Previous revision
projects:content-annotation:guess:article-1 [2007/05/24 09:04]
novak vytvořeno 		projects:content-annotation:guess:article-1 [2007/05/29 10:56] (current)
novak
Line 1: Line 1:
 +===== Annotation =====
 +
 {{projects:content-annotation:guess:englisht-wsj_0023-s1.png|}} {{projects:content-annotation:guess:englisht-wsj_0023-s1.png|}}
 {{projects:content-annotation:guess:englisht-wsj_0023-s2.png|}} {{projects:content-annotation:guess:englisht-wsj_0023-s2.png|}}
 {{projects:content-annotation:guess:englisht-wsj_0023-s3.png|}} {{projects:content-annotation:guess:englisht-wsj_0023-s3.png|}}
 {{projects:content-annotation:guess:englisht-wsj_0023-s4.png|}} {{projects:content-annotation:guess:englisht-wsj_0023-s4.png|}}
 +
 +===== Guesses =====
 +
 +**CB:** Moleculon Inc. acquired Kalipharma for $23 million its affiliate FH Faulding & Co., an Australian pharmaceutical company said.  Kalipharma, a New Jersey-based pharmaceutical company, sells purepac label products.  Faulding said it owns 33% of Moleculon's voting stock and has an agreement to acquire an additional 19%.  That stake in preferred convertible stock holdings gives Faulding the right to increase its interest to 70% of Moleculon's voting stock.
 +
 +**CW:** Australian pharmaceutical company, F.H. Faulding & Company, said its affiliate, Moleculon Inc. has acquired Kalipharma Inc. for $23 million.  Kalipharma, a New Jersey-based pharmaceutical concern, sells its various products under the Purepac label.  Faulding said it owns 33% of Moleculon's voting stock and has the agreement to acquire an additional 19%.  That stake, associated with convertible, preferred stock holdings, gives Faulding the right to increase its interest in Moleculon's voting stock to 70%.
 +
 +
 +===== Original Article =====
 +
 +F.H. Faulding & Co., an Australian pharmaceuticals company, said its Moleculon Inc. affiliate acquired Kalipharma Inc. for $ 23 million. Kalipharma is a New Jersey-based pharmaceuticals concern that sells products under the Purepac label. Faulding said it owns 33% of Moleculon's voting stock and has an agreement to acquire an additional 19%. That stake, together with its convertible preferred stock holdings, gives Faulding the right to increase its interest to 70% of Moleculon's voting stock.
MultiNet (Multilayered Extended Semantic Networks) is developed and maintained
by Intelligent Information and Communication Systems Department of FernUniversität in Hagen.

[ Back to the navigation ] [ Back to the content ]